Novo Nordisk
posted 21 days ago
The position supports the North America Clinical Development (NACD) Clinical Research Equity (CRE) strategy by integrating diversity and health equity into clinical trial planning and execution. The role focuses on creating an inclusive experience for underserved and underrepresented patients and sites, advocating for inclusive trial design, and collaborating with various stakeholders to enhance diverse enrollment in clinical trials.